<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=4423596&amp;fmt=gif">
New fill/finish partnership with BioConnection provides end-to-end drug product development under 1 contract!   Read the press release
Contact Us
Contact Us

AGC Biologics

2 min read

AGC Biologics Completes PPQ Manufacturing with Provention Bio for Type 1 Diabetes Product Candidate, Teplizumab

August 25, 2020 at 7:00 AM
Press Release
Read press release

1 min read

AGC Biologics Enters into Partnership as a CDMO with Ono Pharmaceuticals to Manufacture Biopharmaceuticals at Clinical Development Stage

August 13, 2020 at 6:00 AM
Press Release
Read press release

2 min read

AGC Biologics Expands Partnership with Novavax

August 10, 2020 at 1:05 PM
Press Release
Read press release
AGC Biologics Milan facilities.

1 min read

AGC to Complete the Acquisition of MolMed on July 31, 2020

July 27, 2020 at 7:00 PM
Press Release
Read press release

1 min read

AGC Biologics Expands Development Capacities for pDNA Services at Heidelberg Site

June 30, 2020 at 6:00 AM
Press Release
Read press release

2 min read

Calypso Biotech Completes CALY-002 Clinical Batch Manufacturing

June 18, 2020 at 4:00 AM
Press Release
Read press release

2 min read

Saiba AG Selects AGC Biologics to Develop and Produce COVID-19 Vaccine

June 16, 2020 at 4:00 AM
Press Release
Read press release

1 min read

AGC Biologics Acquires Commercial Facility, Expanding Global Service Offerings

June 1, 2020 at 3:00 PM
Press Release
Read press release

2 min read

Takara Bio Selects AGC Biologics as Manufacturer of Plasmid DNA Intermediate for a Vaccine Against COVID-19 (SARS-CoV-2)

May 20, 2020 at 11:00 PM
Press Release
Read press release

AGC Biologics Manufactures Key Ingredient in Potential COVID-19 Treatment Drug, Leronlimab

April 29, 2020 at 3:49 PM
Press Release
Read press release
1 2 Next